WARREN A ONG
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- WARWICK, RI
- NPI
- 1003896101
- Received
- $806,862 in 846 records, 2019 to 2025
- Person page
- WARREN A ONG Fuzzy (full name with a middle part, and the recipient's state)
- Source
- CMS Open Payments search ↗
On this site
- Person page: Warren A Ong Fuzzy (same full name with a middle name or initial, one person page, in that person's states)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 157 | $128,195 |
| 2024 | General payment | 116 | $98,691 |
| 2023 | General payment | 124 | $148,206 |
| 2022 | General payment | 162 | $162,785 |
| 2021 | General payment | 70 | $77,075 |
| 2020 | General payment | 56 | $50,057 |
| 2019 | General payment | 161 | $141,851 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Neurocrine BioSciences, Inc. | 325 | $320,022 | 2019–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 185 | $195,536 | 2020–2025 |
| Otsuka America Pharmaceutical, Inc. | 137 | $129,092 | 2019–2025 |
| E.R. Squibb & Sons, L.L.C. | 99 | $92,608 | 2024–2025 |
| Teva Pharmaceuticals USA, Inc. | 77 | $60,167 | 2019–2025 |
| Sunovion Pharmaceuticals Inc. | 7 | $7,194 | 2019–2020 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $1,906 | 2019 |
| ABBVIE INC. | 5 | $134 | 2021–2025 |
| Alkermes, Inc. | 4 | $106 | 2024–2025 |
| Lundbeck LLC | 2 | $37 | 2025 |
| Braeburn Inc. | 1 | $22 | 2025 |
| Axsome Therapeutics, Inc. | 1 | $19 | 2025 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 293 | $674,659 |
| Travel and Lodging | 203 | $57,805 |
| Consulting Fee | 16 | $49,350 |
| Food and Beverage | 331 | $24,980 |
| Education | 3 | $66 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-11 | Neurocrine BioSciences, Inc. | $3,088 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-11 | Neurocrine BioSciences, Inc. | $101 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-11 | Lundbeck LLC | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-10 | E.R. Squibb & Sons, L.L.C. | $1 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-04 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $7,015 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,520 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | Braeburn Inc. | $22 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-10 | E.R. Squibb & Sons, L.L.C. | $100 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-10 | E.R. Squibb & Sons, L.L.C. | $88 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-05 | Neurocrine BioSciences, Inc. | $3,088 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-05 | Neurocrine BioSciences, Inc. | $122 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-01 | Neurocrine BioSciences, Inc. | $29 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-30 | E.R. Squibb & Sons, L.L.C. | $1,205 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-30 | E.R. Squibb & Sons, L.L.C. | $108 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $65 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-27 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-23 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | Neurocrine BioSciences, Inc. | $9 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-18 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-17 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Neurocrine BioSciences, Inc. | $9 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-14 | E.R. Squibb & Sons, L.L.C. | $2,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-10 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-10 | E.R. Squibb & Sons, L.L.C. | $1,380 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $869 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-08 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $410 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $275 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $230 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $138 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $59 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $52 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $44 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-01 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-30 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-25 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-25 | E.R. Squibb & Sons, L.L.C. | $115 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-23 | E.R. Squibb & Sons, L.L.C. | $1,007 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-18 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-09-17 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-15 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-11 | E.R. Squibb & Sons, L.L.C. | $909 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-11 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-09 | E.R. Squibb & Sons, L.L.C. | $86 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-02 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-25 | Teva Pharmaceuticals USA, Inc. | $460 | Consulting Fee | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-21 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-16 | Lundbeck LLC | $14 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-12 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-12 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-06 | E.R. Squibb & Sons, L.L.C. | $1,007 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-06 | E.R. Squibb & Sons, L.L.C. | $121 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-31 | Neurocrine BioSciences, Inc. | $30 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-23 | E.R. Squibb & Sons, L.L.C. | $959 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-23 | E.R. Squibb & Sons, L.L.C. | $87 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-23 | E.R. Squibb & Sons, L.L.C. | $28 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-17 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-16 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-26 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-26 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-24 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-10 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-02 | E.R. Squibb & Sons, L.L.C. | $747 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-02 | E.R. Squibb & Sons, L.L.C. | $100 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-30 | E.R. Squibb & Sons, L.L.C. | $26 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-29 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-29 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-29 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-22 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-15 | Neurocrine BioSciences, Inc. | $1,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-15 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-08 | Neurocrine BioSciences, Inc. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-08 | E.R. Squibb & Sons, L.L.C. | $1,610 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-08 | Neurocrine BioSciences, Inc. | $1,401 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-08 | Neurocrine BioSciences, Inc. | $134 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-01 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-01 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-04-30 | E.R. Squibb & Sons, L.L.C. | $913 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-30 | E.R. Squibb & Sons, L.L.C. | $88 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-29 | E.R. Squibb & Sons, L.L.C. | $2,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-29 | E.R. Squibb & Sons, L.L.C. | $130 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-23 | Teva Pharmaceuticals USA, Inc. | $1,470 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-04-23 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-04-16 | E.R. Squibb & Sons, L.L.C. | $460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-16 | E.R. Squibb & Sons, L.L.C. | $77 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-10 | Otsuka America Pharmaceutical, Inc. | $26 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-04-09 | E.R. Squibb & Sons, L.L.C. | $125 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-07 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-03 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-02 | E.R. Squibb & Sons, L.L.C. | $2,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-01 | E.R. Squibb & Sons, L.L.C. | $920 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-01 | E.R. Squibb & Sons, L.L.C. | $460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-31 | E.R. Squibb & Sons, L.L.C. | $920 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-27 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-25 | Neurocrine BioSciences, Inc. | $7,600 | Consulting Fee | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-19 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-13 | E.R. Squibb & Sons, L.L.C. | $666 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-13 | E.R. Squibb & Sons, L.L.C. | $51 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-12 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-12 | E.R. Squibb & Sons, L.L.C. | $0 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-04 | E.R. Squibb & Sons, L.L.C. | $82 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-02 | Neurocrine BioSciences, Inc. | $29 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $1,707 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $485 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $49 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $43 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $36 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $24 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $9 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-01 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-28 | Neurocrine BioSciences, Inc. | $159 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-28 | Neurocrine BioSciences, Inc. | $74 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-25 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-20 | E.R. Squibb & Sons, L.L.C. | $2,070 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-14 | E.R. Squibb & Sons, L.L.C. | $71 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-14 | E.R. Squibb & Sons, L.L.C. | $36 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-13 | Alkermes, Inc. | $31 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-02-06 | Neurocrine BioSciences, Inc. | $1,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-29 | Neurocrine BioSciences, Inc. | $2,763 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-29 | Neurocrine BioSciences, Inc. | $113 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-29 | Neurocrine BioSciences, Inc. | $46 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $3,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $127 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $109 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-28 | E.R. Squibb & Sons, L.L.C. | $31 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-21 | E.R. Squibb & Sons, L.L.C. | $111 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-21 | E.R. Squibb & Sons, L.L.C. | $87 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-21 | E.R. Squibb & Sons, L.L.C. | $83 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-16 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-07 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-01-07 | E.R. Squibb & Sons, L.L.C. | $1,840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2024-12-30 | E.R. Squibb & Sons, L.L.C. | $460 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-19 | E.R. Squibb & Sons, L.L.C. | $66 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-12-19 | E.R. Squibb & Sons, L.L.C. | $41 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-12-19 | E.R. Squibb & Sons, L.L.C. | $25 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-12-18 | E.R. Squibb & Sons, L.L.C. | $6,440 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-12 | E.R. Squibb & Sons, L.L.C. | $136 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-12-12 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-12-11 | E.R. Squibb & Sons, L.L.C. | $63 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-12-05 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-11-21 | Neurocrine BioSciences, Inc. | $2,763 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-21 | Neurocrine BioSciences, Inc. | $125 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-21 | Neurocrine BioSciences, Inc. | $36 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $795 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $249 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $55 | Travel and Lodging | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $50 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $50 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $30 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-11-15 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-10-07 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-09-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-09-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $84 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-21 | Otsuka America Pharmaceutical, Inc. | $877 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-17 | Teva Pharmaceuticals USA, Inc. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-07-17 | Teva Pharmaceuticals USA, Inc. | $94 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-07-17 | Teva Pharmaceuticals USA, Inc. | $18 | Travel and Lodging | Cash or cash equivalent | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $57 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,780 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $618 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $272 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $270 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $226 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $48 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $28 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 |
The latest 200 records of 846.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Warwick, RI, county Kent County, RI, state Rhode Island; placed by its city name.
| Measure | Place (city or town) Warwick, RI | County Kent County, RI | State Rhode Island |
|---|---|---|---|
| Population B01003 | 83,175 | 171,456 | 1,101,801 |
| Population, 2020 census P1 | 82,823 | 170,363 | 1,097,379 |
| Median age B01002 | 44.3 | 43.8 | 40.6 |
| Under 18 B01001 | 17.6% | 18.0% | 18.8% |
| 65 and over B01001 | 21.6% | 20.4% | 18.7% |
| Households B11001 | 36,055 | 72,839 | 441,570 |
| Foreign born B05002 | 7.2% | 7.1% | 15.3% |
| Median household income B19013 | $88,708 | $94,345 | $87,796 |
| Median family income B19113 | $112,976 | $119,830 | $112,375 |
| Per capita income B19301 | $48,016 | $50,854 | $47,150 |
| Poverty rate B17001 | 7.6% | 7.5% | 11.2% |
| Unemployment rate B23025 | 5.1% | 4.7% | 5.8% |
| Civilian labor force B23025 | 46,098 | 95,866 | 594,253 |
| Mean commute (minutes) B08013 | 24.6 | 25.1 | 25.5 |
| Bachelor's degree or higher B15003 | 33.7% | 34.7% | 37.7% |
| Housing units B25001 | 37,516 | 76,529 | 485,932 |
| Owner-occupied B25003 | 73.3% | 73.1% | 63.6% |
| Renters B25003 | 26.7% | 26.9% | 36.4% |
| Median home value B25077 | $354,600 | $366,100 | $404,200 |
| Median gross rent B25064 | $1,363 | $1,327 | $1,342 |
| White, not Hispanic B03002 | 82.1% | 83.7% | 68.0% |
| Black B03002 | 2.5% | 1.9% | 4.9% |
| Hispanic or Latino B03002 | 6.9% | 6.9% | 17.7% |
| Asian B03002 | 3.4% | 2.9% | 3.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Warwick, RI.
Comments